Use of SGLT-2 inhibitors for HF management safe and well tolerated in adult congenital heart disease patients: Study Medha Baranwal20 Feb 2024 6:30 PM ISTUSA: A recent study showed that sodium-glucose transporter 2 inhibitors (SGLT-2i) use appears safe and well tolerated in a small cohort of the adult...
High levels of niacin may induce heart disease, finds Cleveland Clinic-led study Dr. Kamal Kant Kohli20 Feb 2024 10:30 AM ISTCleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common...
Cardio-oncology patients may have a high prevalence of sleep apnea and risk of CHF Dr. Shravani Dali20 Feb 2024 7:00 AM ISTCardio-Oncology Patients may have high prevalence of sleep apnea and risk of CHF suggests a new study published in the American College of...
Migraine and vasomotor symptoms may increase CAD risk among young adults: Study Dr. Shravani Dali20 Feb 2024 2:00 AM ISTMigraine and vasomotor symptoms may increase CAD risk among young adults suggests a new study published in the Menopause.A study was done to examine...
Heart attack significantly increases risk of other serious long-term health conditions: Study Dr. Kamal Kant Kohli20 Feb 2024 12:30 AM ISTHaving a heart attack significantly increases the risk of developing other serious long-term health conditions, a major new study shows. Researchers...
Jaslok Hospital doctors perform Automated Implantable Cardioverter Defibrillator implantation to treat rare heart disease Kajal Rajput19 Feb 2024 9:30 AM ISTMumbai: Jaslok Hospital and Research Centre in Mumbai achieved a remarkable breakthrough in treating an extremely rare heart disease that occurs in...
Systolic BP Variability powerful determinant of CV outcome; amlodipine may render long-term benefit: confirms ASCOT trial Medha Baranwal18 Feb 2024 5:30 PM ISTUK: Systolic blood pressure variability (SBPV) is a strong predictor of cardiovascular (CV) outcomes, even in those with controlled systolic blood...
Lobeglitazone could be promising insulin sensitizer for management of type 2 diabetes in India: SENSITIZE INDIA trial Medha Baranwal18 Feb 2024 5:00 PM ISTIndia: Findings from a randomized, double-blind, phase III SENSITIZE INDIA trial have revealed the safety and efficacy of lobeglitazone 0.5 mg once...
Women with HPV infection face higher risk of death from cardiovascular disease Dr. Kamal Kant Kohli18 Feb 2024 3:45 PM ISTWomen have a four times higher risk of dying from cardiovascular disease if they have an infection with a high-risk strain of the human papillomavirus...
Pioneering French Cardiologist, Inventor of TAVI techique, Dr Alain Cribier no more Kajal Rajput17 Feb 2024 5:54 PM ISTNew Delhi: Pioneering French interventional cardiologist, Dr Alain Cribier, credited with performing the world's first transcatheter aortic valve...
Azelnidipine Demonstrates Efficacy in Lowering BP in Indian Patients with Hypertension: Study Dr Riya Dave17 Feb 2024 10:30 AM ISTHypertension (HTN) is a prevalent cardiovascular condition with significant morbidity and mortality worldwide. Azelnidipine, a selective calcium...
Can Higher HDL levels lead to reversion to normoglycemia from prediabetes? Medha Baranwal17 Feb 2024 10:00 AM ISTChina: An analysis based on data from a retrospective cohort study revealed an independent connection between high-density lipoprotein cholesterol...
